Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/ refractory adult T-cell leukemia/lymphoma

Adrienne A. Phillips, Paul A. Fields, Olivier Hermine, Juan C. Ramos, Brady E. Beltran, Juliana Pereira, Farooq Wandroo, Tatyana Feldman, Graham P. Taylor, Ahmed Sawas, Jeffrey Humphrey, Michael Kurman, Junji Moriya, Karen Dwyer, Mollie Leoni, Kevin Conlon, Lucy Cook, Jason Gonsky, Steven M. Horwitz

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/ refractory adult T-cell leukemia/lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences